83 related articles for article (PubMed ID: 31422574)
21. Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
Torrorey-Sawe R; van der Merwe N; Mining SK; Kotze MJ
Front Genet; 2020; 11():170. PubMed ID: 32231682
[TBL] [Abstract][Full Text] [Related]
22. Implementing genomic screening in diverse populations.
Abul-Husn NS; Soper ER; Braganza GT; Rodriguez JE; Zeid N; Cullina S; Bobo D; Moscati A; Merkelson A; Loos RJF; Cho JH; Belbin GM; Suckiel SA; Kenny EE
Genome Med; 2021 Feb; 13(1):17. PubMed ID: 33546753
[TBL] [Abstract][Full Text] [Related]
23. A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis.
Mouren A; Chansavang A; Hamzaoui N; Srikaran A; Laurent-Puig P; Marisa L; De Percin S; Lupo A; Larousserie F; Blons H; L'Haridon A; Burnichon N; Pasmant E; Tlemsani C
Fam Cancer; 2024 May; ():. PubMed ID: 38763984
[TBL] [Abstract][Full Text] [Related]
24. Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint.
Doi N; Hoshi Y; Itokawa M; Usui C; Yoshikawa T; Tachikawa H
PLoS One; 2009 Nov; 4(11):e7799. PubMed ID: 19911060
[TBL] [Abstract][Full Text] [Related]
25. A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients.
Bianchi A; Zelli V; D'Angelo A; Di Matteo A; Scoccia G; Cannita K; Dimas AS; Glentis S; Zazzeroni F; Alesse E; Di Marco A; Tessitore A
NAR Genom Bioinform; 2024 Jun; 6(2):lqae033. PubMed ID: 38633426
[TBL] [Abstract][Full Text] [Related]
26. Modes of responsibility in disclosing cancer genetic test results to relatives: An analysis of Swiss and Korean narrative data.
Aceti M; Caiata-Zufferey M; Pedrazzani C; Schweighoffer R; Kim SY; Baroutsou V; Katapodi MC; Kim S;
Patient Educ Couns; 2024 Jun; 123():108202. PubMed ID: 38395023
[TBL] [Abstract][Full Text] [Related]
27. Machine Learning-Based Approach Highlights the Use of a Genomic Variant Profile for Precision Medicine in Ovarian Failure.
Henarejos-Castillo I; Aleman A; Martinez-Montoro B; Gracia-Aznárez FJ; Sebastian-Leon P; Romeu M; Remohi J; Patiño-Garcia A; Royo P; Alkorta-Aranburu G; Diaz-Gimeno P
J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34199109
[TBL] [Abstract][Full Text] [Related]
28. Germline mutations in cancer predisposition genes among pediatric patients with cancer and congenital anomalies.
Dangoni GD; Teixeira ACB; da Costa SS; Scliar MO; Carvalho LML; Silva LN; Novak EM; Vince CSC; Maschietto MC; Sugayama SMM; Odone-Filho V; Krepischi ACV
Pediatr Res; 2024 Apr; 95(5):1346-1355. PubMed ID: 38182823
[TBL] [Abstract][Full Text] [Related]
29. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA
BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725
[TBL] [Abstract][Full Text] [Related]
30. Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants.
Nikitin AG; Chudakova DA; Enikeev RF; Sakaeva D; Druzhkov M; Shigapova LH; Brovkina OI; Shagimardanova EI; Gusev OA; Gordiev MG
Front Oncol; 2020; 10():666. PubMed ID: 32547938
[TBL] [Abstract][Full Text] [Related]
31. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
; Dorling L; Carvalho S; Allen J; González-Neira A; Luccarini C; Wahlström C; Pooley KA; Parsons MT; Fortuno C; Wang Q; Bolla MK; Dennis J; Keeman R; Alonso MR; Álvarez N; Herraez B; Fernandez V; Núñez-Torres R; Osorio A; Valcich J; Li M; Törngren T; Harrington PA; Baynes C; Conroy DM; Decker B; Fachal L; Mavaddat N; Ahearn T; Aittomäki K; Antonenkova NN; Arnold N; Arveux P; Ausems MGEM; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Białkowska K; Blomqvist C; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Bremer M; Briceno I; Brüning T; Burwinkel B; Cameron DA; Camp NJ; Campbell A; Carracedo A; Castelao JE; Cessna MH; Chanock SJ; Christiansen H; Collée JM; Cordina-Duverger E; Cornelissen S; Czene K; Dörk T; Ekici AB; Engel C; Eriksson M; Fasching PA; Figueroa J; Flyger H; Försti A; Gabrielson M; Gago-Dominguez M; Georgoulias V; Gil F; Giles GG; Glendon G; Garcia EBG; Alnæs GIG; Guénel P; Hadjisavvas A; Haeberle L; Hahnen E; Hall P; Hamann U; Harkness EF; Hartikainen JM; Hartman M; He W; Heemskerk-Gerritsen BAM; Hillemanns P; Hogervorst FBL; Hollestelle A; Ho WK; Hooning MJ; Howell A; Humphreys K; Idris F; Jakubowska A; Jung A; Kapoor PM; Kerin MJ; Khusnutdinova E; Kim SW; Ko YD; Kosma VM; Kristensen VN; Kyriacou K; Lakeman IMM; Lee JW; Lee MH; Li J; Lindblom A; Lo WY; Loizidou MA; Lophatananon A; Lubiński J; MacInnis RJ; Madsen MJ; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Maurer T; Mavroudis D; McLean C; Meindl A; Mensenkamp AR; Michailidou K; Miller N; Mohd Taib NA; Muir K; Mulligan AM; Nevanlinna H; Newman WG; Nordestgaard BG; Ng PS; Oosterwijk JC; Park SK; Park-Simon TW; Perez JIA; Peterlongo P; Porteous DJ; Prajzendanc K; Prokofyeva D; Radice P; Rashid MU; Rhenius V; Rookus MA; Rüdiger T; Saloustros E; Sawyer EJ; Schmutzler RK; Schneeweiss A; Schürmann P; Shah M; Sohn C; Southey MC; Surowy H; Suvanto M; Thanasitthichai S; Tomlinson I; Torres D; Truong T; Tzardi M; Valova Y; van Asperen CJ; Van Dam RM; van den Ouweland AMW; van der Kolk LE; van Veen EM; Wendt C; Williams JA; Yang XR; Yoon SY; Zamora MP; Evans DG; de la Hoya M; Simard J; Antoniou AC; Borg Å; Andrulis IL; Chang-Claude J; García-Closas M; Chenevix-Trench G; Milne RL; Pharoah PDP; Schmidt MK; Spurdle AB; Vreeswijk MPG; Benitez J; Dunning AM; Kvist A; Teo SH; Devilee P; Easton DF
N Engl J Med; 2021 Feb; 384(5):428-439. PubMed ID: 33471991
[TBL] [Abstract][Full Text] [Related]
32. Rare
Moyer CL; Ivanovich J; Gillespie JL; Doberstein R; Radke MR; Richardson ME; Kaufmann SH; Swisher EM; Goodfellow PJ
Cancer Res; 2020 Feb; 80(4):857-867. PubMed ID: 31822495
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of Germline
Santonocito C; Rizza R; Paris I; Marchis L; Paolillo C; Tiberi G; Scambia G; Capoluongo E
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32438681
[TBL] [Abstract][Full Text] [Related]
34. Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients.
Jarhelle E; Riise Stensland HMF; Hansen GÅM; Skarsfjord S; Jonsrud C; Ingebrigtsen M; Strømsvik N; Van Ghelue M
Sci Rep; 2019 Dec; 9(1):19986. PubMed ID: 31882575
[TBL] [Abstract][Full Text] [Related]
35. Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Felicio PS; Grasel RS; Campacci N; de Paula AE; Galvão HCR; Torrezan GT; Sabato CS; Fernandes GC; Souza CP; Michelli RD; Andrade CE; Barros BDF; Matsushita MM; Revil T; Ragoussis J; Couch FJ; Hart SN; Reis RM; Melendez ME; Tonin PN; Carraro DM; Palmero EI
Hum Mutat; 2021 Mar; 42(3):290-299. PubMed ID: 33326660
[TBL] [Abstract][Full Text] [Related]
36. Population-based targeted sequencing of 54 candidate genes identifies
Song H; Dicks EM; Tyrer J; Intermaggio M; Chenevix-Trench G; Bowtell DD; Traficante N; Group A; Brenton J; Goranova T; Hosking K; Piskorz A; van Oudenhove E; Doherty J; Harris HR; Rossing MA; Duerst M; Dork T; Bogdanova NV; Modugno F; Moysich K; Odunsi K; Ness R; Karlan BY; Lester J; Jensen A; Krüger Kjaer S; Høgdall E; Campbell IG; Lázaro C; Pujara MA; Cunningham J; Vierkant R; Winham SJ; Hildebrandt M; Huff C; Li D; Wu X; Yu Y; Permuth JB; Levine DA; Schildkraut JM; Riggan MJ; Berchuck A; Webb PM; Group OS; Cybulski C; Gronwald J; Jakubowska A; Lubinski J; Alsop J; Harrington P; Chan I; Menon U; Pearce CL; Wu AH; de Fazio A; Kennedy CJ; Goode E; Ramus S; Gayther S; Pharoah P
J Med Genet; 2021 May; 58(5):305-313. PubMed ID: 32546565
[TBL] [Abstract][Full Text] [Related]
37. Frequency spectrum of rare and clinically relevant markers in multiethnic Indian populations (ClinIndb): A resource for genomic medicine in India.
Narang A; Uppilli B; Vivekanand A; Naushin S; Yadav A; Singhal K; Shamim U; Sharma P; Zahra S; Mathur A; Seth M; Parveen S; Vats A; Hillman S; Dolma P; Varma B; Jain V; ; Prasher B; Sengupta S; Mukerji M; Faruq M
Hum Mutat; 2020 Nov; 41(11):1833-1847. PubMed ID: 32906206
[TBL] [Abstract][Full Text] [Related]
38. Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test.
Shin HC; Lee HB; Yoo TK; Lee ES; Kim RN; Park B; Yoon KA; Park C; Lee ES; Moon HG; Noh DY; Kong SY; Han W
Cancer Res Treat; 2020 Jul; 52(3):697-713. PubMed ID: 32019277
[TBL] [Abstract][Full Text] [Related]
39. Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.
Urbina-Jara LK; Rojas-Martinez A; Martinez-Ledesma E; Aguilar D; Villarreal-Garza C; Ortiz-Lopez R
Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31658756
[TBL] [Abstract][Full Text] [Related]
40. Novel Genetic Markers for Early Detection of Elevated Breast Cancer Risk in Women.
Wu B; Peng Y; Eggert J; Alexov E
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
